India orders top drugmaker to halt eye medicine production at plant over quality lapses
Indian regulators have escalated action against India’s largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory …Read More
Related news articles...
-
Cheap data is great for Indians but not for India’s reputation – The Economist
by Newsbot · Published November 1, 2026
-
India protests: Thousands gather in New Delhi, demanding election chief’s resignation
by Newsbot · Published November 1, 2026
-
New Zealand vs India – Scorecard & Stats – Sky Sports
by Newsbot · Published November 1, 2026
-
Thousands join Indian opposition protest demanding election chief’s resignation – CNBC
by Newsbot · Published November 1, 2026
-
Rahul Gandhi Leads Opposition’s ‘Vote Chori’ Campaign Against CEC – YouTube
by Newsbot · Published November 1, 2026
-
India’s Pharmaceutical Industry | Economic and Political Weekly
by Newsbot · Published October 30, 2026
-
Overall Green Flood in India from 20 Oct 2026 01:00 UTC to 30 Oct 2026 01:00 UTC – GDACS
by Newsbot · Published October 30, 2026
-
How Jio Transformed India, One Cheap Byte at a Time – Bloomberg.com
by Newsbot · Published October 30, 2026
-
Pfizer looks to reroute supply after flooding sidelined India injectables plant – Fierce Pharma
by Newsbot · Published October 30, 2026
-
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
by Newsbot · Published October 30, 2026